| 2023 | YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
| CANCERS |
| 2023 | Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
| SCIENTIFIC REPORTS |
| 2023 | Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer
| JAMA NETWORK OPEN |
| 2023 | Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer
| YONSEI MEDICAL JOURNAL |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy
| FRONTIERS IN ONCOLOGY |
| 2023 | Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy | RADIOLOGY |
| 2023 | Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
| CANCER MEDICINE |
| 2022 | Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
| 2022 | 18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence
| SCIENTIFIC REPORTS |
| 2022 | Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer
| JAMA NETWORK OPEN |
| 2022 | Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer
| CANCERS |
| 2022 | Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
| DIAGNOSTICS |
| 2022 | CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer | SCIENCE IMMUNOLOGY |
| 2022 | Effects of Single Nucleotide Polymorphisms and Mediterranean Diet in Overweight or Obese Postmenopausal Women With Breast Cancer Receiving Adjuvant Hormone Therapy: A Pilot Randomized Controlled Trial
| FRONTIERS IN NUTRITION |
| 2022 | RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis | BREAST CANCER RESEARCH AND TREATMENT |
| 2022 | SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer
| CANCERS |
| 2022 | Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR
| NPJ BREAST CANCER |
| 2022 | Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer
| NPJ BREAST CANCER |
| 2022 | Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography-a prospective study | EUROPEAN RADIOLOGY |
| 2021 | The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy
| CANCERS |
| 2021 | Relationship of the standard uptake value of 18 F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm
| SCIENTIFIC REPORTS |
| 2021 | Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution | RADIOLOGY |
| 2021 | From cadaveric and animal studies to the clinical reality of robotic mastectomy: A feasibility report of training program
| SCIENTIFIC REPORTS |
| 2021 | PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection
| SCIENTIFIC REPORTS |
| 2021 | Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer
| INTERNATIONAL JOURNAL OF CANCER |
| 2021 | Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer
| CANCERS |
| 2021 | Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk
| CANCERS |
| 2021 | Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
| BREAST CANCER RESEARCH AND TREATMENT |
| 2021 | Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients
| BRITISH JOURNAL OF CANCER |
| 2021 | Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
| FRONTIERS IN ONCOLOGY |
| 2021 | The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients
| PLOS ONE |
| 2021 | Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
| JOURNAL OF BREAST CANCER |
| 2021 | High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer
| FRONTIERS IN ONCOLOGY |
| 2020 | Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy | BREAST CANCER RESEARCH AND TREATMENT |
| 2020 | Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction
| BREAST |
| 2020 | Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
| SCIENTIFIC REPORTS |
| 2020 | Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence After Breast Conserving Surgery With Sentinel Lymph Node Biopsy: Pooled Analysis Using Data From a Systematic Review and Two Institutions
| FRONTIERS IN ONCOLOGY |
| 2020 | Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy | CLINICAL BREAST CANCER |
| 2020 | Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy
| SCIENTIFIC REPORTS |
| 2020 | Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis | BREAST CARE |
| 2020 | Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer
| CANCERS |
| 2020 | Associations between absolute neutrophil count and lymphocyte-predominant breast cancer
| BREAST |
| 2020 | Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
| CANCERS |
| 2020 | A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer
| EUROPEAN RADIOLOGY |
| 2019 | Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer
| JOURNAL OF BREAST CANCER |
| 2019 | High A20 expression negatively impacts survival in patients with breast cancer
| PLoS One |
| 2019 | Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV
| ENDOCRINE-RELATED CANCER |
| 2019 | Immediate Breast Reconstruction Does Not Have a Clinically Significant Impact on Adjuvant Treatment Delay and Subsequent Survival Outcomes
| JOURNAL OF BREAST CANCER |
| 2019 | A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patients | BREAST CANCER RESEARCH AND TREATMENT |
http://orcid.org/0000-0002-0012-9694
